Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study.

Kardosh A, Lichtensztajn DY, Gubens MA, Kunz PL, Fisher GA, Clarke CA.

Pancreas. 2018 Sep;47(8):958-966. doi: 10.1097/MPA.0000000000001133.

PMID:
30074526
2.

Risk of Kaposi sarcoma after solid organ transplantation in the United States.

Cahoon EK, Linet MS, Clarke CA, Pawlish KS, Engels EA, Pfeiffer RM.

Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31735. [Epub ahead of print]

PMID:
29987894
3.

Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.

Kwon GP, Gamba CS, Stefanick ML, Swetter SM, Li S, Shi RZ, Clarke CA, Feldman D, Millen AE, Messina C, Shikany JM, Manson JE, Chlebowski RT, Tang JY.

J Am Acad Dermatol. 2018 Jul;79(1):145-147. doi: 10.1016/j.jaad.2017.05.037. No abstract available.

PMID:
29908819
4.

Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.

Tota JE, Engels EA, Madeleine MM, Clarke CA, Lynch CF, Ortiz AP, Hernandez BY, Chaturvedi AK.

Cancer. 2018 Jun 15;124(12):2515-2522. doi: 10.1002/cncr.31359. Epub 2018 Apr 12.

PMID:
29645080
5.

Pediatric neuro-oncology survival disparities in California.

Cooney T, Fisher PG, Tao L, Clarke CA, Partap S.

J Neurooncol. 2018 May;138(1):83-97. doi: 10.1007/s11060-018-2773-0. Epub 2018 Feb 7.

PMID:
29417400
6.

Characterizing the neighborhood obesogenic environment in the Multiethnic Cohort: a multi-level infrastructure for cancer health disparities research.

Conroy SM, Shariff-Marco S, Yang J, Hertz A, Cockburn M, Shvetsov YB, Clarke CA, Abright CL, Haiman CA, Le Marchand L, Kolonel LN, Monroe KR, Wilkens LR, Gomez SL, Cheng I.

Cancer Causes Control. 2018 Jan;29(1):167-183. doi: 10.1007/s10552-017-0980-1. Epub 2017 Dec 8.

PMID:
29222610
7.

Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.

Lin CY, Carneal EE, Lichtensztajn DY, Gomez SL, Clarke CA, Jensen KC, Kurian AW, Allison KH.

Am J Clin Pathol. 2017 Sep 1;148(3):199-207. doi: 10.1093/ajcp/aqx063.

PMID:
28821197
8.

Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.

Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA.

Cancer. 2017 Dec 1;123(23):4663-4671. doi: 10.1002/cncr.30923. Epub 2017 Jul 31.

PMID:
28759103
9.

Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012.

Clarke CA, McKinley M, Hurley S, Haile RW, Glaser SL, Keegan THM, Swetter SM.

J Invest Dermatol. 2017 Nov;137(11):2282-2290. doi: 10.1016/j.jid.2017.06.024. Epub 2017 Jul 21.

PMID:
28736233
10.

Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.

Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KK.

Ann Surg Oncol. 2017 Nov;24(12):3502-3509. doi: 10.1245/s10434-017-6009-x. Epub 2017 Jul 19.

PMID:
28726077
11.

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.

Chavez-MacGregor M, Mittendorf EA, Clarke CA, Lichtensztajn DY, Hunt KK, Giordano SH.

Oncologist. 2017 Nov;22(11):1292-1300. doi: 10.1634/theoncologist.2017-0116. Epub 2017 Jun 7.

PMID:
28592619
12.

Cancer Risk After Pediatric Solid Organ Transplantation.

Yanik EL, Smith JM, Shiels MS, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA.

Pediatrics. 2017 May;139(5). pii: e20163893. doi: 10.1542/peds.2016-3893.

13.

Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.

Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM.

Br J Haematol. 2017 Jul;178(1):72-80. doi: 10.1111/bjh.14638. Epub 2017 May 25.

14.

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.

Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2017 May 1;19(1):52. doi: 10.1186/s13058-017-0840-7.

15.

Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.

Gomez SL, Von Behren J, McKinley M, Clarke CA, Shariff-Marco S, Cheng I, Reynolds P, Glaser SL.

Breast Cancer Res Treat. 2017 Jul;164(1):139-147. doi: 10.1007/s10549-017-4229-1. Epub 2017 Apr 1.

16.

Variation in risk and outcomes of Epstein-Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study.

Glaser SL, Canchola AJ, Keegan TH, Clarke CA, Longacre TA, Gulley ML.

Cancer Causes Control. 2017 Apr;28(4):273-287. doi: 10.1007/s10552-017-0865-3. Epub 2017 Feb 22.

PMID:
28229344
17.

Contextual Impact of Neighborhood Obesogenic Factors on Postmenopausal Breast Cancer: The Multiethnic Cohort.

Conroy SM, Clarke CA, Yang J, Shariff-Marco S, Shvetsov YB, Park SY, Albright CL, Hertz A, Monroe KR, Kolonel LN, Marchand LL, Wilkens LR, Gomez SL, Cheng I.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):480-489. doi: 10.1158/1055-9965.EPI-16-0941. Epub 2017 Jan 31.

18.

Recent declines in cancer incidence: related to the Great Recession?

Gomez SL, Canchola AJ, Nelson DO, Keegan TH, Clarke CA, Cheng I, Shariff-Marco S, DeRouen M, Catalano R, Satariano WA, Davidson-Allen K, Glaser SL.

Cancer Causes Control. 2017 Feb;28(2):145-154. doi: 10.1007/s10552-016-0846-y. Epub 2017 Jan 27.

PMID:
28130633
19.

Lifestyle Medicine: A Primary Care Perspective.

Clarke CA, Hauser ME.

J Grad Med Educ. 2016 Dec;8(5):665-667. doi: 10.4300/JGME-D-15-00804.1. No abstract available.

20.

Prevalence and characteristics of cancer patients receiving care from single vs. multiple institutions.

Clarke CA, Glaser SL, Leung R, Davidson-Allen K, Gomez SL, Keegan TH.

Cancer Epidemiol. 2017 Feb;46:27-33. doi: 10.1016/j.canep.2016.11.001. Epub 2016 Dec 3.

21.

HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.

Hussain SK, Makgoeng SB, Everly MJ, Goodman MT, Martínez-Maza O, Morton LM, Clarke CA, Lynch CF, Snyder J, Israni A, Kasiske BL, Engels EA.

Transplantation. 2016 Nov;100(11):2453-2460.

22.

Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013.

Kurian AW, Canchola AJ, Gomez SL, Clarke CA.

Breast Cancer Res Treat. 2016 Nov;160(2):333-338. Epub 2016 Sep 24.

23.

Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.

Wapnir IL, Kurian AW, Lichtensztajn DY, Clarke CA, Gomez SL.

Ann Surg. 2017 Aug;266(2):353-360. doi: 10.1097/SLA.0000000000001972.

24.

Public Reporting of Hospital-Level Cancer Surgical Volumes in California: An Opportunity to Inform Decision Making and Improve Quality.

Clarke CA, Asch SM, Baker L, Bilimoria K, Dudley RA, Fong N, Holliday-Hanson ML, Hopkins DS, Imholz EM, Malin J, Moy L, O'Sullivan M, Parker JP, Saigal CS, Spurlock B, Teleki S, Zingmond D, Lang L.

J Oncol Pract. 2016 Oct;12(10):e944-e948.

PMID:
27601510
25.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guénel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menéndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Brüning T, Ko YD, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K; Australian Ovarian Cancer Study Group, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnæs GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rüdiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park J, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Høgdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Górski B, Gronwald J, Menkiszak J, Høgdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL.

J Med Genet. 2016 Dec;53(12):800-811. doi: 10.1136/jmedgenet-2016-103839. Epub 2016 Sep 5.

26.

Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population.

Tao L, Chu L, Wang LI, Moy L, Brammer M, Song C, Green M, Kurian AW, Gomez SL, Clarke CA.

Cancer Causes Control. 2016 Sep;27(9):1127-38. doi: 10.1007/s10552-016-0791-9. Epub 2016 Aug 5.

PMID:
27496200
27.

Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study.

Ma H, Xu X, Clague J, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley J, Neuhausen SL, Bernstein L.

Breast Cancer Res. 2016 Jun 17;18(1):62. doi: 10.1186/s13058-016-0723-3.

28.

Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients.

Martínez ME, Anderson K, Murphy JD, Hurley S, Canchola AJ, Keegan TH, Cheng I, Clarke CA, Glaser SL, Gomez SL.

Cancer. 2016 May 15;122(10):1570-8. doi: 10.1002/cncr.29886. Epub 2016 Apr 11.

29.

Effects of marital status and economic resources on survival after cancer: A population-based study.

Gomez SL, Hurley S, Canchola AJ, Keegan TH, Cheng I, Murphy JD, Clarke CA, Glaser SL, Martínez ME.

Cancer. 2016 May 15;122(10):1618-25. doi: 10.1002/cncr.29885. Epub 2016 Apr 11.

30.

Strategies for recruiting representative samples of Asian Americans for a population-based case-control study.

Wong CK, Horn-Ross PL, Gee GC, Shariff-Marco S, Quach T, Allen L, Bautista R, La Chica PQ, Tseng W, Chang P, Clarke CA, Yang J, Le GM, Canchola A, Irwin ML, Lee SS, Gomez SL.

J Epidemiol Community Health. 2016 Oct;70(10):974-82. doi: 10.1136/jech-2015-206905. Epub 2016 Apr 6.

PMID:
27053683
31.

Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA.

Br J Haematol. 2016 Aug;174(3):417-24. doi: 10.1111/bjh.14073. Epub 2016 Mar 28.

32.

Residential cancer cluster investigation nearby a Superfund Study Area with trichloroethylene contamination.

Press DJ, McKinley M, Deapen D, Clarke CA, Gomez SL.

Cancer Causes Control. 2016 May;27(5):607-13. doi: 10.1007/s10552-016-0734-5. Epub 2016 Mar 17.

33.

Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.

Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, Glaser SL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):264-73. doi: 10.1158/1055-9965.EPI-15-0756. Epub 2016 Jan 29.

34.

Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma.

Arron ST, Raymond AK, Yanik EL, Castenson D, McCulloch CE, Clarke CA, Paddock LE, Niu X, Engels EA.

Dermatol Surg. 2016 Feb;42(2):157-66. doi: 10.1097/DSS.0000000000000602.

PMID:
26818209
35.

Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

Gomez SL, Yang J, Lin SW, McCusker M, Sandler A, Patel M, Cheng I, Wakelee HA, Clarke CA.

J Glob Oncol. 2016 Jan 20;2(1):30-38. doi: 10.1200/JGO.2015.000539. eCollection 2016 Feb.

36.

Characterizing subsequent primary melanomas (SPM) in adolescents and young adults: A population-based study from 1973 to 2011.

Fu T, Swetter SM, Tao L, Geller AC, Clarke CA, Keegan TH.

J Am Acad Dermatol. 2016 Jan;74(1):181-182.e3. doi: 10.1016/j.jaad.2015.09.003. No abstract available.

37.

Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.

Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH.

JAMA Oncol. 2016 Mar;2(3):322-9. doi: 10.1001/jamaoncol.2015.3856.

38.

Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.

Yanik EL, Clarke CA, Snyder JJ, Pfeiffer RM, Engels EA.

J Am Soc Nephrol. 2016 May;27(5):1495-504. doi: 10.1681/ASN.2015040373. Epub 2015 Nov 12.

39.

Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort.

Wang SS, Deapen D, Voutsinas J, Lacey JV Jr, Lu Y, Ma H, Clarke CA, Weisenburger D, Forman SJ, Bernstein L.

Br J Haematol. 2016 Aug;174(3):480-3. doi: 10.1111/bjh.13779. Epub 2015 Oct 12. No abstract available.

40.

Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults.

Keegan THM, Swetter SM, Tao L, Sunwoo JB, Clarke CA.

J Invest Dermatol. 2015 Dec;135(12):3195-3197. doi: 10.1038/jid.2015.325. Epub 2015 Aug 19. No abstract available.

41.

Melanoma Risk and Survival among Organ Transplant Recipients.

Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, Paddock L, Yanik EL, Lynch CF, Kasiske BL, Snyder J, Engels EA.

J Invest Dermatol. 2015 Nov;135(11):2657-2665. doi: 10.1038/jid.2015.312. Epub 2015 Aug 13.

42.

Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Glaser SL, Clarke CA, Keegan TH, Chang ET, Weisenburger DD.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1474-88. doi: 10.1158/1055-9965.EPI-15-0281. Epub 2015 Jul 27.

43.

Indicators of microbial-rich environments and the development of papillary thyroid cancer in the California Teachers Study.

Clarke CA, Reynolds P, Oakley-Girvan I, Lee E, Lu Y, Yang J, Moy LM, Bernstein L, Horn-Ross PL.

Cancer Epidemiol. 2015 Aug;39(4):548-53. doi: 10.1016/j.canep.2015.04.014. Epub 2015 May 23.

44.

Incidence trends of lung cancer by immigration status among Chinese Americans.

Gomez SL, Yang J, Lin SW, McCusker M, Sandler A, Cheng I, Wakelee HA, Patel M, Clarke CA.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1157-64. doi: 10.1158/1055-9965.EPI-15-0123. Epub 2015 May 19.

45.

Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.

Tao L, Gomez SL, Keegan TH, Kurian AW, Clarke CA.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1039-45. doi: 10.1158/1055-9965.EPI-15-0243. Epub 2015 May 12.

46.

Hodgkin lymphoma incidence in ethnic enclaves in California.

Glaser SL, Chang ET, Clarke CA, Keegan TH, Yang J, Gomez SL.

Leuk Lymphoma. 2015;56(12):3270-80. doi: 10.3109/10428194.2015.1026815. Epub 2015 Jun 18.

47.

The thylakoid membrane protein CGL160 supports CF1CF0 ATP synthase accumulation in Arabidopsis thaliana.

Fristedt R, Martins NF, Strenkert D, Clarke CA, Suchoszek M, Thiele W, Schöttler MA, Merchant SS.

PLoS One. 2015 Apr 2;10(4):e0121658. doi: 10.1371/journal.pone.0121658. eCollection 2015.

48.

Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis.

Percival ME, Tao L, Medeiros BC, Clarke CA.

Cancer. 2015 Jun 15;121(12):2004-12. doi: 10.1002/cncr.29319. Epub 2015 Mar 4.

49.

Risk of merkel cell carcinoma after solid organ transplantation.

Clarke CA, Robbins HA, Tatalovich Z, Lynch CF, Pawlish KS, Finch JL, Hernandez BY, Fraumeni JF Jr, Madeleine MM, Engels EA.

J Natl Cancer Inst. 2015 Jan 8;107(2). pii: dju382. doi: 10.1093/jnci/dju382. Print 2015 Feb.

50.

Cancer research in Asian American, Native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity.

Gomez SL, Glaser SL, Horn-Ross PL, Cheng I, Quach T, Clarke CA, Reynolds P, Shariff-Marco S, Yang J, Lee MM, Satariano WA, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2202-5. doi: 10.1158/1055-9965.EPI-14-0624.

Supplemental Content

Loading ...
Support Center